Hormone Therapy (IMAGE)

Bentham Science Publishers

Hormone Therapy

Caption

This graph shows the progression free survival from hormone therapy in 37 endocrine-dependent metastatic breast cancer patients (by the Kaplan-Meier method); median survival time and 95 percent CI: Luminal (n=28) 33, 20.6-45.4 months; non-Luminal (n=9) 32, 23.2-40.7 months.

Credit

Dr. Andrea Nicolini et al., Bentham Science Publishers

Usage Restrictions

Image rights belong to Dr. Andrea Nicolini et al., Bentham Science Publishers

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.